PRELOAD PRELOAD PRELOAD PRELOAD PRELOAD

Media

Media

Welcome to BioMarin's Online Press Room.

We've brought together a variety of information in one location to better assist you in your efforts to research and develop news articles. Should you require additional information, please call or e-mail us any time.

Contact Information:
415-455-7451
corporatecommunications2@BMRN.com

Recent News

  • BioMarin Announces Two Oral and 19 Poster Presentations at the Society for the Study of Inborn Errors of Metabolism 2015 Annual Meeting...  MORE >
  • Medivation to Expand Global Oncology Franchise With the Acquisition of All Worldwide Rights to Talazoparib (BMN 673), a Potent PARP Inhibitor, From BioMarin...  MORE >
  • BioMarin Receives Rare Pediatric Disease Designation From FDA for Drisapersen for the Potential Treatment of Duchenne Muscular Dystrophy...  MORE >